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ABSTRACT 
Background: Post-stroke pneumonia and other infectious complications are serious 
conditions whose frequency varies widely across studies.   
Aims: We conducted a systematic review to estimate the frequency of post-stroke pneumonia 
and other types of major infection. 
Summary of review: MEDLINE, EMBASE, CINAHL and PsycINFO databases were 
searched for prospective studies with consecutive recruitment of stroke patients.  The primary 
outcome was post-stroke pneumonia.  Secondary outcomes were any infection and urinary 
tract infection.  Quality assessment was done using Newcastle Ottawa scale.  Heterogeneity 
of estimates across study populations was calculated using Cochran’s Q (heterogeneity 2) 
and I2 statistics. A total of 47 studies (139,432 patients) with 48 sample populations were 
eligible for inclusion.  Mean age of patients was 68.3 years and their mean National Institute 
of Health Stroke Scale score was 8.2.  The pooled frequency of post-stroke pneumonia was 
12.3% (95% confidence interval [CI] 11%-13.6%; I2=98%).  The pooled frequency from 
2011 to 2017 was 13.5% (95% CI 11.8%-15.3%; I2=98%) and comparable with earlier 
periods (P interaction=0.31).  The pooled frequency in studies in stroke units was 8% (95% 
CI 7.1%-9%; I2=78%) and significantly lower than other locations (P interaction=0.001).  
The pooled frequency of post-stroke infection was 21% (95%CI 13%-29.3%; I2=99%) and of 
post-stroke urinary tract infection was 7.9% (95% CI 6.7%-9.3%; I2=96%). 
Conclusion:  Approximately 1 in 10 stroke patients experience pneumonia during the acute 
period of hospital care.  The frequency of post-stroke pneumonia has remained stable in 
recent decades but is lower in patients receiving stroke unit care compared to management in 
other ward settings. 
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INTRODUCTION 
 Stroke is the second leading cause of death in high-income countries 1-3. The overall 
burden due to stroke is even greater in middle and low-income countries 3, 4. The global 
burden of disease study suggests that stroke will remain one of the leading causes of 
disability-adjusted life years (DALYs) in the near future. Pneumonia is the major early 
complication of stroke and is associated with high morbidity and mortality 5, 6. Pneumonia by 
itself is also associated with poor functional outcomes and the prevalence has varied from 5 
to 10 patients per 1000 population 7. The frequency of post-stroke pneumonia varies widely 
within and over time in the literature with ranges reported from 1.4% to 57% 8, 9.  
While major risk factors for post-stroke pneumonia include older age, dysphagia, 
male gender, stroke severity, pre-admission dependency, coronary artery disease, congestive 
cardiac failure, and chronic obstructive pulmonary disease, it has also been regarded as a 
marker of stroke severity 10, 11. In the last 10 years, there have been enormous advances in 
primary and secondary stroke and care, including an emphasis on stroke unit care 12, 13. We 
undertook a systematic review of the frequency of post-stroke pneumonia and its relationship 
with pathological stroke subtype and type of stroke care over time.  
 
METHODS 
This systematic review was conducted according to the MOOSE guidelines and reported 
according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) 14-16. The protocol is registered in the International prospective register of 
systematic reviews (PROSPERO) (CRD20171221) at 
https://www.crd.york.ac.uk/PROSPEROFILES/78368_PROTOCOL_20171221.pdf  (see 
supplementary files) 
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Search strategy and selection criteria 
MEDLINE (Medical Literature Analysis and Retrieval System Online) via Ovid, 
EMBASE (Excerpta Medical Database) and CENTRAL (Cochrane Central Register of 
Controlled Trials), CINAHL (Cumulative index to nursing and allied health literature) and 
PsycINFO were searched from inception to October 2017 using search strategies specified in 
the registered protocol. Studies were eligible for inclusion if they: (1) were prospective 
cohort studies with consecutive recruitment; (2) involved adult patients (age ≥18 years) 
admitted within 30 days of acute ischaemic or haemorrhagic stroke; and (3) reported the 
proportion of patients with post-stroke pneumonia. There were no language restrictions or 
study size exclusions. Studies were excluded if they were randomised controlled trials, case-
control or cross-sectional studies or had retrospective recruitment. Studies with overlapping 
recruitment sites, study dates, funding grant numbers and similar patient characteristics were 
considered to be from the same cohort and in that case the study with the largest cohort was 
included. This occurred in three instances 5, 9, 17.  
Data extraction and quality assessment 
Two authors (M.S.B. and Z.Z.) independently evaluated all citations by title and 
abstract and retrieved the full text in detail for those that appeared relevant. One author 
(M.S.B) extracted data which were checked by another author (Z.Z).  Methodological quality 
of the included studies was assessed using the Newcastle Ottawa scale including assessment 
of the representativeness of the cohort 18. Since this was a study of frequency of post-stroke 
pneumonia, exposure was not studied and selection of the unexposed cohort, ascertainment of 
exposure and comparability of cohorts on the basis of design or analysis were not applicable. 
Demonstration that post-stroke pneumonia was not present at the outset, assessment of 
outcome and follow-up length and adequacy of cohort follow-up were assessed. Since post-
stroke pneumonia usually is an acute medical complication not requiring prolonged 
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observation or follow-up, all studies with in-hospital observation of post-stroke pneumonia 
were defined as having an adequate (one star) follow-up length. Studies with follow-up post-
discharge were considered to have a good follow up. 
Outcome measures 
The primary study outcome was the frequency of post-stroke pneumonia defined by 
any diagnostic method.  Secondary outcomes were frequencies of post-stroke infections, and 
urinary tract infection after acute stroke. The authors’ criteria for the diagnosis of post-stroke 
pneumonia were based on history and clinical features (cough, purulent secretions, fever, 
leucocytosis), infiltrates on chest x-ray, staining and culture of the causative microorganism, 
and frequently were also based on established criteria for the diagnosis of post-stroke 
pneumonia, Mann criteria and Centre for Disease control (CDC) criteria (Online 
supplementary files). Ventilator-associated pneumonia was defined as pneumonia developing 
in patients receiving mechanical ventilation. The authors’ criteria for the diagnosis of 
pneumonia, infection and urinary tract infection were accepted.  
Dysphagia assessment was done by doctors and/or nurses and/or specialist speech 
pathologists (speech and language therapists). Criteria used in studies included were clinical, 
and/or radiologic and/or endoscopic.  History and clinical examination including assessment 
of bulbar function, testing for dysarthria, dysphonia and voluntary cough, symmetry and 
speed of tongue and palatal movements were done to diagnose dysphagia clinically. Clinical 
criteria used to diagnose dysphagia were the swallowing provocation test, water swallow test, 
staged water swallow test, three-step swallowing screen protocol, Paramatta Hospital 
assessment of dysphagia and ROSS test (Online supplementary files, Supplementary Table 
1). The radiologic methods used were the modified barium swallow or videofluoroscopic 
evaluation of swallowing (VFES). The endoscopic methods used to diagnose dysphagia were 
fibreoptic endoscopic evaluation of swallowing (FEES). 
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Subgroup analyses were conducted according to location (stroke unit and ward 
[including patients treated in a combination of stroke unit and ward or neurology ward or 
medical ward], only stroke unit, intensive care unit [ICU] with ward and emergency 
department), according to type of stroke (only ischaemic stroke, ischaemic stroke and 
intracerebral haemorrhage and only intracerebral haemorrhage), according to the aim of the 
study (studies specifically evaluating infection after acute stroke versus other studies), 
according to era (before 1990, 1991-2000, 2001-2010 and 2011onward ) and according to 
interventions received by the patient populations (intravenous thrombolysis, intra-arterial 
interventions, intensive care unit interventions, nasogastric tubes and all other interventions). 
We extracted data for dependence and stroke severity if the National Institute of Health 
stroke scale (NIHSS) was used (see supplementary files). 
Data Synthesis and Analysis 
Pooled proportion of post-stroke pneumonia was calculated using the random-effects 
approach of DerSimonian and Laird 19. Sub-group meta-analyses of proportion with post-
stroke pneumonia were conducted as described earlier. Heterogeneity of the frequency of 
post-stroke pneumonia between study populations was calculated using Cochran’s Q 
(heterogeneity 2) and I2 statistics 20. I2 values of less than 25%, 50% to less than 75% and 
more than 75% were regarded as evidence of low, moderate and high levels of inconsistency 
respectively 20 . Subgroups were compared using random-effects meta-regression analyses to 
assess the effects of type of stroke, location of patient, era, World Bank country/region 
economy ranking, type of study and intervention used on the frequency of post-stroke 
pneumonia. Publication bias was assessed by Begg and Mazumdar rank correlation test 21. 
Analyses were conducted using Stata/MP (version 14.2, Stat Corp, College Station, Texas). 
 8 
Role of funding source 
This study had no funding. The corresponding author had access to all data and took 
final responsibility for submission of this paper. 
 
RESULTS 
Selection and description of studies 
Electronic searching retrieved 2331 citations from MEDLINE, EMBASE, CINAHL 
and PsycINFO (Figure 1). Sixty studies were identified from reference lists and added to the 
original list. Three hundred and sixty duplicate citations were excluded leaving 2031 
citations. After screening, 1826 were excluded, and 205 full text articles were assessed for 
eligibility. A total of 48 sample populations in 47 studies were eligible and included in the 
meta-analyses.  Forty-seven studies including 139,432 stroke patients met the inclusion 
criteria (Table 1; Supplementary Table 2).  
Median study size was 310 (range 100- 63650) and mean study size was 2966 (Table 
1). Studies were primarily conducted in the ward and stroke unit setting (28 studies;111409 
participants), followed by only in the stroke unit setting (14 studies; 26942 participants), ICU 
and ward setting (4 studies; 798 participants) and emergency department (1 study; 283 
participants) (1). In the study populations, where data were reported, the mean age of 
participants was 68.3 years, 51.7 % were male, and their mean baseline National Institute of 
Health Stroke Scale (NIHSS) score was 8.2. One fifth (22.7%) of patients had dysphagia, 
17% had nasogastric tubes (one study of 100 participants only included patients with 
nasogastric tubes 22) and 17.3% had lowered consciousness 22. The data on patients with 
nasogastric tubes and lowered consciousness were from separate studies except for one study 
22. The proportion of patients with dysphagia without lowered consciousness where data was 
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available (5 studies) was 52.5% (Table 1). The number of days of observation in the hospital 
ranged from 2 to 21 days. Follow-up after discharge from hospital occurred in ten studies and 
this ranged from 14 to 90 days. 
Quality assessment 
All studies scored one star for representativeness of the cohort and assessment of 
outcome (Figure 2). Only 7 studies explicitly stated that pneumonia was not present at the 
start of the study. All studies scored one star for assessment of outcome. All studies scored 
one star indicating an adequate length of follow-up. However, in only ten studies did follow-
up continue after discharge indicative of good follow-up length. There was adequate cohort 
follow-up only in the ten studies with follow-up continuing after discharge. 
Pooled frequency of post-stroke pneumonia and subgroup analyses 
The pooled frequency of post-stroke pneumonia in the included studies was 12.3% 
(95% confidence interval [CI] 11.1%-13.6%; I2=98%) (Figure 3). The pooled frequency in 
the studies including only patients treated in stroke units (14 studies; 26,942 participants) was 
8% (95% CI 7.1%-9%; I2=78%) and this was statistically less than the pooled frequency in 
patients treated in the ward and stroke unit (28 studies; 111,409 participants, 13.1% [95% CI 
11.3%-14.9%; I2=98%]) (P interaction=0.001) 5, 23-26. The pooled proportion of patients with 
post-stroke pneumonia in ICUs (4 studies; 798 participants) was 30.3% (95% CI 12.9%-
47.6%; I2=97%), and much higher than other pooled estimates based on patient location 
(Table 2) 8, 27-30. In ICU studies, the frequency of ventilator-associated post-stroke pneumonia 
in intubated and ventilated patients (2 studies; 36 participants) was 80.6% (95% CI 67.8%-
93.6%; I2=0%) and this was even higher than the frequency of post-stroke pneumonia in ICU 
patients. 
 10 
The pooled frequency of post-stroke pneumonia in patients with intracerebral haemorrhage (2 
studies; 5423 participants) was 16.8% (95% CI 15.8%-17.8%; I2=0%) and comparable with 
the pooled frequency of post-stroke pneumonia in patients with only ischaemic stroke (24 
studies; 35252 participants, 11.7% [95% CI 9.2%-14.1%; I2=98%]) and patients with 
intracerebral haemorrhage and ischaemic stroke (22 studies; 98757 participants, 11.7% [95% 
CI 10.3%-13%; I2=96%]) (P interaction=0.37)  (Table 2) 31.  
The pooled frequency of post-stroke pneumonia from 2011-2017 (17 studies; 106406 
participants, 13.6% [95% CI 11.8%-15.3%; I2=98%]) was comparable with 1991-2000 (5 
studies; 734 participants, 9.9% (95% CI 5.46%-14.29%; I2=78%) and 2001-2010 (25 studies; 
32188 participants, 11.8% (95% CI 9.9%-13.7%; I2=97%) (P interaction=0.31) (Table 2). 
There was only one study assessing the frequency of post-stroke pneumonia in a low-income 
country (148 participants, 18.2% [95% CI 12%-14.5%]). This was comparable with the 
pooled frequencies in high-income countries or regions (38 studies; 114450 participants, 
11.7% [95% CI 10.4%-13%; I2=98%]) and middle-income countries or regions (8 studies; 
24834 participants, 13.8% [95% CI 11.3%-16.2%; I2=87%]) (P interaction=0.77) (Table 2).  
In studies aimed at specifically evaluating post-stroke infections (20 studies; 74187 
participants) the pooled frequency was 16.5% (95% CI 13.8%-19.2%; I2=98%) which was 
higher than that found in other studies not aimed at specifically studying post-stroke 
infections (28 studies; 65245 participants, 10% [95% CI 8.7%-11.4%; I2=96%]) and 
statistically significant (P interaction=0.01) (Table 2).  The frequency of post-stroke 
pneumonia in patients with nasogastric tubes (1 study; 100 participants) was 44% (95% CI 
34.2%-53.7%) and the pooled frequency in patients receiving interventions in ICU (4 studies; 
798 participants) was 30.2% (95% CI 12.9%-47.6%; I2=97%) and these were higher than 
10.5% (95% CI 9.2%-11.7%; I2=98%) in patients receiving other interventions (40 studies; 
137831participants), intravenous thrombolysis (1 study; 538 participants, 22.7% [95% CI 
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19.5%-26.2%]) and intra-arterial interventions (1 study; 165 participants, 13.3% [95% CI 
8.1%-18.5%]) and this was not a statistically significant interaction (P interaction=0.5) (Table 
2). In the primary and sub-group analyses of the frequency of post-stroke pneumonia, 
heterogeneity was high (I2 =78%-98%) except for the 2 sample populations with intracerebral 
haemorrhage and ventilator-associated post-stroke pneumonia (I2 =0%).  
Pooled frequency of post-stroke infections and post-stroke urinary tract infection 
The pooled frequency of post-stroke infection (11 studies; 8581 participants) was 
21% (95% CI 13%-29.3%) (Figure 4) with high statistical heterogeneity (I2 =99%). The 
pooled frequency of post-stroke urinary tract infection (28 studies; 39282 participants) was 
7.9% (95% CI 6.7%-9.3%) (Figure 5) with high statistical heterogeneity (I2 =96%).  
Meta-regression analysis and small study effects 
Significant interaction between the sub-groups of care location of patients (stroke unit 
and ward, stroke unit, ICU and ward, emergency), type of study (aim of study focussing on 
post-stroke infection and/or post-stroke pneumonia, other studies) were identified in meta-
regression. There was no statistically significant interaction for the other sub-group (type of 
stroke, era, country income and interventions used [ICU interventions, nasogastric tubes, 
intravenous thrombolysis, intra-arterial thrombolysis and/or clot retrieval, other 
interventions]) analyses. When funnel plots were examined for small study effects, these 
were symmetrical suggesting that there was no evidence of publication bias. 
 
DISCUSSION 
In this large systematic review and meta-analysis, the point estimate of the pooled 
frequency of post-stroke pneumonia was 12.3%. The point estimate of pooled frequency of 
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post-stroke pneumonia in the present era (2011 onward) remains unchanged from previous 
years. It is surprising that there is no evidence of a reduction in the frequency of post-stroke 
pneumonia over time given the great advances in stroke care and acute stroke therapies.  This 
could possibly be explained by increased survival of patients with more severe strokes with 
improved stroke care 32. Increased stroke severity leads to an increased tendency to develop 
post-stroke pneumonia due to dysphagia and depressed consciousness. The lack of reduction 
in the post-stroke pneumonia frequency could also be attributed to better awareness, methods 
of detection and reporting bias. The relatively small number of included patients receiving 
thrombolysis and/or clot retrieval may also explain the consistent frequency of post-stroke 
pneumonia over time. Over the last twenty-five years the absolute number of stroke survivors 
and people with new stroke has increased one to two- fold.  Most of this increased burden is 
in developing countries yet most of the studies included in our review are from high-income 
countries 33. However, the increase in stroke burden does not necessarily indicate that 
affected persons have increased stroke severity.  
The pooled frequency of post-stroke pneumonia was higher in ICU patients and in the 
study exclusively including patents with nasogastric tubes, reflecting the inclusion of patients 
with more severe strokes, on ventilators and with an increased tendency to have medical 
complications including pneumonia. Among patients in ICUs with endotracheal intubation 
and mechanical ventilation, the frequency of ventilator- associated post-stroke pneumonia 
was much higher than other patients. Bundles are methods to implement best practices. The 
ventilator-associated pneumonia ‘prevention’ bundle can reduce the incidence of pneumonia 
by at least 50% 34. The prevention bundle mainly includes elevation of head of the bed by 30 
to 45 (head elevation is not recommended if cerebral perfusion pressure is threatened), daily 
sedation interruption and assessment of readiness to extubate, use of subglottic secretion 
drainage and avoidance of scheduled ventilator circuit changes 35-37. Other additions to this 
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bundle are the use of oral chlorhexidine antiseptic to prevent pneumonia, peptic ulcer disease 
prophylaxis and deep vein thrombosis prophylaxis 36. In the study exclusively including 
patients with nasogastric tubes the frequency of pneumonia was high probably since all the 
patients had dysphagia, one-fifth of these had lowered level of consciousness, and severe 
upper motor neuron facial palsy with paresis of the tongue and oropharyngeal muscles was 
seen in many patients 22.  
The pooled frequency of post-stroke pneumonia was comparable in populations of 
patients with intracerebral haemorrhage and patients with ischaemic stroke. This may be due 
to improvements in post-stroke care that despite the increased severity of the clinical 
presentation in patients with intracerebral haemorrhage, the frequency of post-stroke 
pneumonia is not significantly higher than patients with ischaemic stroke. The pooled 
frequency of post-stroke pneumonia was lowest in stroke units indicating that stroke unit care 
may be effective in preventing post-stroke pneumonia. This is probably due to better facilities 
and clinical protocols in place in stroke units including dysphagia management to prevent 
aspiration. The pooled frequency of post-stroke infection was higher than post-stroke 
pneumonia and apart from post-stroke pneumonia, this also included post-stroke urinary tract 
infections, acute bronchitis, upper respiratory tract infections, viral infections, fever of 
unknown origin and other infections 38-45. The frequency of post-stroke urinary tract 
infections was similar to previous studies 6.  
This is the largest systematic review and meta-analysis including high quality studies 
with prospective, consecutive recruitment providing data on the frequency of post-stroke 
pneumonia. Scores on the Newcastle- Ottawa scale indicated fair to good quality for most 
studies with poor quality in very few instances in the domains studied. There are limited new 
data on the frequency of post-stroke infection, post-stroke pneumonia and urinary tract 
infection and research in this area is needed considering the poor outcomes associated 6, 46. 
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We should acknowledge the clinical heterogeneity which included varying stroke populations 
with differing quality of stroke care and stroke severity. There are only two studies with 
patients with intracerebral haemorrhage indicative of overall bias in the pooled data for the 
frequency of post-stroke pneumonia, post-stroke infections and urinary tract infection after 
ischaemic stroke 17, 31. There are also limited data from middle-income and low-income 
countries/regions to inform clinical practice, probably due to the expense and infrastructure 
required to conduct prospective consecutive cohort studies over a reasonable time period. 
Since our search terms were primarily linked to respiratory infections, we may have missed 
studies with only data on the frequency of post-stroke infection and urinary tract infection. 
There is scope for a large prospective cohort study of post-stroke pneumonia and 
post-stroke infections, in stroke units, in patients who have received thrombolysis and/or clot 
retrieval to determine whether the frequency of post-stroke pneumonia is lower in people 
receiving these interventions. Considering the expense of such a study, it may not be possible 
in a developing country, at least not over a long period of time. 
In the last ten years, stroke has been named a prioritized noncommunicable disease by 
the World Health Organisation 33. Given the unchanged frequency of post-stroke pneumonia 
in the present decade and the economic burden that it poses, this review indicates that there 
needs to be more robust practices in place for the prevention of post-stroke pneumonia 
globally. Though post-stroke pneumonia is an infection of the lung parenchyma due to 
invasion and overgrowth of micro-organisms, administration of prophylactic antibiotics has 
not been shown to improve outcomes of acute stroke patients in two recent large randomised 
trials 47, 48. Hence, after hospital admission of patients with acute stroke other appropriate 
preventive strategies including dysphagia screening, good nursing care, handwashing and 
aseptic precautions would need to be used to prevent pneumonia and other infections. In this 
systematic review, since stroke unit care was associated with the lowest frequency of post-
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stroke pneumonia, we would advocate for all patients with acute stroke to receive stroke unit 
care. Ventilator-associated pneumonia prevention bundles can help in reducing the incidence 
of pneumonia in ICU and we would recommend consideration of these bundles when patients 
with acute stroke are treated in ICUs. Primary and secondary stroke prevention may also play 
an important role in preventing post-stroke pneumonia by reducing stroke severity. Research 
on the predictors of post-stroke pneumonia and other infections would be useful to put 
appropriate preventive strategies in place. 
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Table 1: Characteristics of patients in studies included 
Patient characteristics N 
139,432 
 
Mean study size 2,966 
Mean age of patients (years) (42 studies) 68.3 
Number of male patients (44 studies) 71,885 (51.8) 
Mean NIHSS score (11 studies) 8.2 
Nasogastric tubes (9 studies) 663 (17%) 
Lowered consciousness (14 studies) 
Lowered consciousness with nasogastric tube (1 study) 
Normal consciousness with nasogastric tube (1 study) 
Dysphagia (16 studies) 
Dysphagia without lowered consciousness (5 studies) 
2,038 (17.3%) 
21 (21%) 
79 (79%) 
1,785 (22.7%) 
367 (52.5%) 
Disorders of the urinary tract (4 studies) 1,858 (11%) 
  
NIHSS = National Institute of Health stroke scale 
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Numbers are N (%) unless otherwise indicated 
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Table 2. Subgroup analyses of the pooled frequency of post-stroke pneumonia 
 
Subgroup 
classification 
Subgroup Number of studies 
or sample 
populations 
Number of 
Participants 
Pooled frequency in 
percent (95% CI) 
I2 P 
interaction 
Patient location 0.001 
 Stroke unit 14 26,942   8% (7.1%-9%) 78%  
 Ward and stroke unit 28 111,409 13.1% (11.3%-14.9%) 98%  
 ICU and ward 4 798 30.3% (12.9%-47.6%) 97%  
 Emergency 1 283    9.1% (5.8%-12.5%) -  
Type of stroke 0.37 
 Intracerebral haemorrhage 2 5,423 16.8% (15.8%-17.8%) 0%  
 Ischaemic stroke 24 35,252 11.7% (9.2%-14.1%) 98%  
 Intracerebral haemorrhage 
and ischaemic stroke 
22 98,757 11.7% (10.3%-13%) 96%  
Era/ decade 0.31 
 1991- 2000 5 734 9.9% (5.4%-14.3%) 78%  
 2001- 2010 25 32,188 11.8% (9.9%-13.7%) 97%  
 2011- 2017 17 106,406 13.6% (11.8%-15.3%) 98%  
Country/region income 0.77 
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Subgroup 
classification 
Subgroup Number of studies 
or sample 
populations 
Number of 
Participants 
Pooled frequency in 
percent (95% CI) 
I2 P 
interaction 
 High-income 38 114,450   11.7% (10.4%-13%) 98%  
 Middle-income 8 24,834 13.8% (11.3%-16.2%) 87%  
 Low-income 1 148    18.2% (12%-14.5%) -  
Study aimed at specifically evaluating post-stroke infections 0.01 
 Yes 20 74,187 16.5% (13.8%-19.2%) 98%  
 No 27 65,245    10% (8.7%-11.4%) 96%  
Interventions used 0.5 
 Nasogastric tubes 1 100   44% (34.2%-53.7%) -  
 ICU related 4 798   30.3% (12.9%-47.6%)      97%  
 Intravenous thrombolysis 1 538 22.7% (19.5%-26.2%) -  
 Intra-arterial interventions 1 165   13.3% (8.1%-18.5%) -  
 Other interventions 40 137,831 10.5% (9.2%-11.7%) 98%  
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Legends for figures 
Figure 1. PRISMA Flow Diagram Showing Selection of Studies 
Figure 2. Quality assessment by the Newcastle-Ottawa Scale 
Figure 3.  Forest plot showing the pooled frequency of post-stroke pneumonia 
Figure 4.  Forest plot showing the pooled frequency of post-stroke infections 
Figure 5. Forest plot showing the pooled frequency of post-stroke urinary tract infection 
 
 
